
Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
HQ location
San Francisco, United States
Website
Launch date
Employees
Market cap
$262m
Enterprise value
$68m
Share price
$1.18 ALLO
Recent deals
Authorizing premium user...